Rare diseases, repurposing and the role of AI
pharmaphorum
OCTOBER 16, 2020
These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data. The post Rare diseases, repurposing and the role of AI appeared first on.
88 
Let's personalize your content